While metformin did not affect aromatase levels within the mammary tumor cells, we did find a significant decrease in the number of aromatase-positive stromal cells in the tumor border of metformin-treated animals compared with controls (Fig. 5a). This evidence concerns the gene CYP19A1 and breast cancer.